In multiple myeloma, high levels of enzyme ADAR1 are associated with reduced survival
Multiple myeloma is the second most common blood cancer in the United States. Thirty to 50 percent of multiple myeloma patients have extra copies of the gene that encodes the enzyme ADAR1. Using a database of multiple myeloma ...
Dec 5, 2017
0
2